|
Index of reports
> Cases with Viith Nerve Paralysis (3)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Omnitrope (Somatropin Subcutaneous) where reactions include viith nerve paralysis. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Omnitrope side effects in male
Reported by a health professional (non-physician/pharmacist) from Poland on 2012-05-01
Patient: male, weighing 42.0 kg (92.4 pounds)
Reactions: Viith Nerve Paralysis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Omnitrope
Dosage: 1.2 mg to 1.1 mg
Indication: Growth Hormone Deficiency
Start date: 2011-12-21
End date: 2012-03-05
Omnitrope
Dosage: 0.02 mg/kg, unk
Start date: 2012-04-12
Possible Omnitrope side effects in male
Reported by a health professional (non-physician/pharmacist) from Poland on 2012-04-17
Patient: male, weighing 42.0 kg (92.4 pounds)
Reactions: Viith Nerve Paralysis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Omnitrope
Dosage: 1.2 mg to 1.1 mg
Indication: Growth Hormone Deficiency
Start date: 2011-12-21
End date: 2012-03-05
Omnitrope
Dosage: 0.02 mg/kg, unk
Start date: 2012-04-12
Possible Omnitrope side effects in male
Reported by a health professional (non-physician/pharmacist) from Poland on 2012-03-19
Patient: male, weighing 42.0 kg (92.4 pounds)
Reactions: Viith Nerve Paralysis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Omnitrope
|
